Ovarian cancer trials in Switzerland

In Switzerland 13 Also abroad 794

13 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Where
Bern, Geneva, Zurich
Age
18 years and over
People
111 worldwide
Run by
Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00
Phase 3Taking people
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Where
Baden, Bellinzona, Chur, Geneva
Age
18 years and over
People
1,630 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07213804 · EU 2025-522255-25-00
Phase 1/2Taking people
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003).
Where
Basel, Lausanne, Sankt Gallen
Age
18 years and over
People
605 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06843447 · EU 2024-514674-47-00
No phaseTaking people
OV Precision: Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy
Where
Aarau, Baden, Basel, Bern, Frauenfeld, Fribourg, Lucerne, Sankt Gallen, Winterthur, Zurich
Age
18 years and over
People
60
Run by
Swiss GO Trial Group
See details and how to joinNCT06466382
Phase 3Taking people
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Where
Bellinzona, Chur, Frauenfeld, Geneva, Lausanne, Zurich
Age
18 years and over
People
466 worldwide
Run by
Incyte Corporation
See details and how to joinNCT07214779 · EU 2025-522748-42-00
Phase 3Taking people
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Where
Bellinzona, Bern, Chur, Geneva
Age
18 years and over
People
900 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07318558 · EU 2023-508047-40-00
Phase 2Taking people
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Where
Basel, Bellinzona, Sankt Gallen
Age
18 years to 130 years
People
454 worldwide
Run by
AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00
Phase 2Taking people
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Where
Bellinzona, Chur, Geneva, Lausanne
Age
18 years to 99 years
People
160 worldwide
Run by
Incyte Corporation
See details and how to joinNCT07023627 · EU 2025-521513-14-00
Phase 3Taking people
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
Where
Basel, Münsterlingen, Sankt Gallen, Thun, Zollikerberg, Zurich
Age
18 years and over
People
1,100 worldwide
Run by
AstraZeneca
See details and how to joinNCT07218809 · EU 2025-520466-22-00
Phase 1Taking people
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Where
Chur, Lausanne
Age
18 years and over
People
1,006 worldwide
Run by
Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04389632 · EU 2023-508469-34-00
No phaseTaking people
Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland
Where
Basel, Bellinzona, Bern, Delémont, Fribourg, Geneva, Winterthur
Age
18 years and over
People
700
Run by
University of Basel
See details and how to joinNCT03124212
No phaseTaking people
The Immune Landscape of Epithelial Ovarian Cancer
Where
Bellinzona
Age
18 years and over
People
74
Run by
Oncology Institute of Southern Switzerland
See details and how to joinNCT05984875
Phase 3Taking people
MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)
Where
Aarau, Baden, Basel, Bellinzona, Bern, Chur, Frauenfeld, Geneva, Grabs, Lausanne, Liestal, Lucerne, Münsterlingen, Sankt Gallen, Sion, Winterthur, Zurich
Age
18 years and over
People
540 worldwide
Run by
Swiss GO Trial Group
See details and how to joinNCT04111978 · EU 2024-511219-78-00